In an urgent situation like the Covid pandemic, the drug regulator has the authority to give approval for restricted use to a vaccine based on its safety and immunogenicity data from phase 1 and 2 studies while phase 3 clinical trial is under way, Indian Council of Medical Research (ICMR) chief Balram Bhargava said on Tuesday.source https://timesofindia.indiatimes.com/india/no-irregularity-in-approval-to-covaxin-icmr/articleshow/80125344.cms
Comments
Post a Comment